NCT07019961

Brief Summary

The goal of this clinical trial is to learn if GMA-TULIP laryngeal mask willfit well in the right place in participants undergoing trauma surgery in a supine position under general anaesthesia. It will also learn about the convenience, effectiveness and safety of the GMA-TULIP laryngeal mask. The main questions it aims to answer are: Does the GMA-TULIP laryngeal mask exhibit better anatomical alignment? Does the GMA-TULIP laryngeal mask perform effectively in trauma surgery patients in a supine position under general anaesthesia? Researchers will compare with the i-gel laryngeal mask (a device already popular among anaesthetists) to see if the GMA-TULIP laryngeal mask works to have a good performance in general anaesthesia. Participants will describe feelings immediately after anesthesia, 1 hour later and 24 hours later.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
198

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2025

Completed
Last Updated

June 13, 2025

Status Verified

March 1, 2025

Enrollment Period

5 months

First QC Date

June 5, 2025

Last Update Submit

June 5, 2025

Conditions

Keywords

GMA-TULIP laryngeal maski-gel laryngeal maskanatomical alignment of laryngeal maskoropharyngeal leak pressure

Outcome Measures

Primary Outcomes (1)

  • Accuracy of anatomical alignment under fiberoptic bronchoscopy observation

    Class I: Vocal cords visible. Class II: Vocal cords and posterior epiglottis visible. Class III: Vocal cords and anterior epiglottis visible, \<50% visual obstruction of epiglottis to vocal cords. Class IV: Vocal cords and anterior epiglottis visible, \>50% visual obstruction of epiglottis to vocal cords. Class V: Vocal cords not visible. We define Class I and II field of view as accurate alignment; Class III and IV vision are defined as poor alignment; Class V vision is defined as alignment failure.

    After insertion of laryngeal mask

Secondary Outcomes (13)

  • Number of laryngeal mask insertions

    After anesthesia induction

  • Placement time of laryngeal mask

    After anesthesia induction

  • Difficulty level of laryngeal mask insertion

    After insertion of laryngeal mask

  • Time of insertion of gastric tube through laryngeal mask airway

    After insertion of laryngeal mask

  • Number of gastric tube insertions

    After insertion of laryngeal mask

  • +8 more secondary outcomes

Study Arms (2)

G group

EXPERIMENTAL

Participants who will use the GMA-TULIP laryngeal mask

Device: the GMA-TULIP laryngeal mask

I Group

ACTIVE COMPARATOR

Participants who will use the i-gel laryngeal mask

Device: the i-gel laryngeal mask

Interventions

insert GMA-TULIP laryngeal masks after anesthesia induction

G group

insert i-gel laryngeal masks after anesthesia induction

I Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old ≤ age ≤ 70 years old. Patients undergoing trauma surgery in a supine position under general anesthesia.
  • kg/m2 ≤ BMI ≤ 35 kg/m2. American Society of Anesthesiologists (ASA) grades I-III. Can understand the research process and the use of pain scales. Clear understanding and voluntary participation in the study, signing of informed consent form.

You may not qualify if:

  • Patients with known or predicted difficult airways. High risk of reflux or aspiration (e.g., gastroesophageal reflux disease patients).
  • Individuals with active upper respiratory tract infections. Cervical related diseases or surgical history. Preoperative sore throat or previous sore throat or hoarseness. Patients with oral and maxillofacial trauma or fractures. Other reasons why researchers believe it is not appropriate to participate in the experiment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

Location

Study Officials

  • Shaozhong Yang, Doctor

    Qilu Hospital of Shandong University

    STUDY CHAIR

Central Study Contacts

Shaozhong Yang, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 13, 2025

Study Start

July 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 3, 2025

Last Updated

June 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

After the research is completed, share research data, research plans, statistical analysis plans, informed consent forms, and other data

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR

Locations